Financial For Lutherans Thrivent bought $15M of TAKNX
owner at Carlyle Tactical Private Credit Fund. 600,000 shares at an average of $25.00, traded Apr 2, 2025, filed Apr 3, 2025.
Score components
- +12Role10% owner
- +25Trade size$15.0M at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +10Price context1% above the 52-week low
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000314984-25-000033, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 2, 2025 | POpen-market purchase Mandatory Redeemable Preferred Shares, Series K | +600,000 | $25.00 | $15M | 600,000 | Apr 3, 2025 |
Related signals
Other insiders at Carlyle Tactical Private Credit Fund and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 59Moderate | Carlyle Tactical Private Credit Fund | Corebridge Financial, Inc. other | $40M 1,600,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.